<DOC>
<DOCNO>EP-0650958</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Hydrazones of indane-triones and their application in therapy
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D21300	C07D295215	C07D24100	A61K3144	C07D21388	A61K3144	C07D24124	C07C25184	C07C25100	C07D29500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	C07D	A61K	C07D	A61K	C07D	C07C	C07C	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D213	C07D295	C07D241	A61K31	C07D213	A61K31	C07D241	C07C251	C07C251	C07D295	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The derivatives of the present invention correspond to the general formula: 
<
IMAGE
>
 in which Ar is a substituted or unsubstituted aromatic ring or a heteroaromatic ring with one or a number of hetero atoms, with the exception of the phenyl radical and of the pyridyl radical.
 
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Hydrazones of indane-triones characterized by the
general formula :



wherein Ar is a 1-pyrrolyl group.
Addition mineral salts selected from hydrochloric
acid, bromhydric acid, sulfuric acid, phosphoric acid and

nitric acid and addition organic salts selected from acetic
acid, propionic acid, oxalic acid, citric acid,

maleic acid, fumaric acid, succinic acid and tartric acid
of compounds having the general formula :



wherein Ar is a 3-pyridyl group.
Use of the compounds according to one of claims 1
and 2 for the manufacture of a drug for the treatment of

organic and functional blood insufficiency.
Use of the compounds according to one of claims 1
and 2 for the manufacture of a drug for the treatment of

hemorrhoidal pathologies.
Use of the compounds according to one of claims 1
and 2 for the manufacture of a drug for the treatment of 

osteoarticular, dermatological and cardio-vascular inflammatory
infections.
Use of the compounds according to one of claims 1
and 2 for the manufacture of a drug for the treatment of

shock states resulting from a significative drop of blood
pressure particularly of septic shock states.
Use of 2,3-dihydro-1,3-dioxo-2-(3-pyridylcarbonyl-hydrazono)-1H-indene
for the manufacture of a

drug for the treatment of organic and functional blood
insufficiency.
Use of 2,3-dihydro-1,3-dioxo-2-(3-pyridylcarbonyl-hydrazono)-1H-indene
for the manufacture of a

drug for the treatment of hemorrhoidal pathologies.
Use of 2,3-dihydro-1,3-dioxo-2-(3-pyridylcarbonyl-hydrazono)-1H-indene
for the manufacture of a

drug for the treatment of osteoarticular, dermatological
and cardio-vascular inflammatory infections.
Use of 2,3-dihydro-1,3-dioxo-2-(3-pyridylcarbonyl-hydrazono)-1H-indene
for the manufacture of a

drug for the treatment of shock states resulting from a
significative drop of blood pressure particularly of septic

shock states.
</CLAIMS>
</TEXT>
</DOC>
